Microwave Ablation Market (By Component Type: Generator, Power Distribution System; By Application: Oncology, Cardiovascular, Urology, Orthopedic; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The global microwave ablation market was estimated at USD 133.41 million in 2021 and it is expected to surpass around USD 289.92 million by 2030, poised to grow at a CAGR of 9.01% from 2022 to 2030.

Microwave Ablation Market Size 2021 to 2030

The microwave ablation market is growing rapidly due to its increasing incidences of tumors of the liver, lung, bone, and kidney globally. Additionally, a growing number of processes with the image-guided device is also expected to fuel the growth of the market. Technical advancements and a rising preference for minimally invasive surgeries is also expected to witness the growth of microwave ablation devices in near future. However, the high cost of devices used during the microwave ablation procedures and the preference for radiofrequency ablation devices over microwave ablation (MWA) devices by the respective surgeons is hindering the market growth.

Microwave ablation (MWA) is a thermal technology, that incorporates MRI and radio-frequency equipment for the treatment of various benign and malignant tumors. Microwave ablation is being explored for an assortment of restorative treatments including treatment of endometrial bleeding, uterine myomas, atrial fibrillation, and cancerous tumors within the liver, kidneys, pancreas, lungs, and breast. MWA offers a less-invasive elective to surgical resection of tumors, allowing shortened recovery times and offering a rational treatment choice for cancer patients who are not candidates for surgery. The microwave ablation procedure uses the most technically advanced devices that provide short ablation time, higher temperature for the ablation, weakened heat-sink effect than that of radiofrequency ablations, and large ablation zones. These factors are proven to improve tumor ablation efficacy using the MWA process.

The microwave ablation market is segmented based on component type into the generator, power distribution system, and accessories. Based on application, the microwave ablation market is segmented into oncology, cardiovascular, urology, orthopedic, and others. Additionally, based on the end-user, the market is segmented into hospitals, ambulatory surgical centers, and research laboratories.

The companies are working on developing innovative microwave ablation systems with the help of their research and innovation. For instance, In July 2020, Ethicon (Subsidiary of Johnson & Johnson Medical Devices Company) announced that the U.S. Food and Drug Administration (FDA) has approved their NEUWAVE Microwave Ablation System. Additionally, Medtronic plc has declared the breakthrough device designation status grant for the Emprint ablation catheter kit from the U.S. Food and Drug Administration (FDA), in April 2021. However, the higher number of product recalls may also impede market growth. For instance, the Solero Microwave Tissue Ablation (MTA) System and accessories from Angiodynamics Inc. has been terminated in June 2020 due to a lack of updates from the manufacturers to decrease the potential risks to patients due to delay in performing the procedure.

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 133.41 million
Revenue Forecast by 2030 USD 289.92 million 
Growth rate from 2022 to 2030 CAGR of 9.01%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation Component Type, Application, End-user, Region
Companies Covered

Angio Dynamics, Boston Scientific Corporation, Emblation microwave, Huber+Suhner, Johnson & Johnson Services Inc., Med Waves, Medtronic PLC, MedWaves Inc., Miramar labs, Neu Wave Medical, Pearson Medical, Symple Surgical, Urologix, Vison Medical USA Inc.

 

Key Players

  • Angio Dynamics
  • Boston Scientific Corporation
  • Emblation microwave
  • Huber+Suhner
  • Johnson & Johnson Services Inc.
  • Med Waves
  • Medtronic PLC
  • MedWaves Inc.
  • Miramar labs
  • Neu Wave Medical
  • Pearson Medical
  • Symple Surgical
  • Urologix
  • Vison Medical USA Inc.

Market Segmentation

  • By Component Type
    •  Generator
    • Power Distribution System
    • Accessories
  • By Application
    • Oncology
    • Cardiovascular
    • Urology
    • Orthopedic
    • Others
  • By End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Research Laboratories
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Microwave Ablation Market 

5.1. COVID-19 Landscape: Microwave Ablation Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Microwave Ablation Market, By Component Type

8.1. Microwave Ablation Market, by Component Type, 2022-2030

8.1.1 Generator

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Power Distribution System

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Accessories

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Microwave Ablation Market, By Application

9.1. Microwave Ablation Market, by Application, 2022-2030

9.1.1. Oncology

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Cardiovascular

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Urology

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Orthopedic

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Microwave Ablation Market, By End-user 

10.1. Microwave Ablation Market, by End-user, 2022-2030

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Ambulatory Surgical Centers

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Research Laboratories

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Microwave Ablation Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.1.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.3. Market Revenue and Forecast, by End-user (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.4.3. Market Revenue and Forecast, by End-user (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.5.3. Market Revenue and Forecast, by End-user (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.2.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.3. Market Revenue and Forecast, by End-user (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.4.3. Market Revenue and Forecast, by End-user (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.5.3. Market Revenue and Forecast, by End-user (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.6.3. Market Revenue and Forecast, by End-user (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.7.3. Market Revenue and Forecast, by End-user (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.3.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.3. Market Revenue and Forecast, by End-user (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.4.3. Market Revenue and Forecast, by End-user (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.5.3. Market Revenue and Forecast, by End-user (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.6.3. Market Revenue and Forecast, by End-user (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.7.3. Market Revenue and Forecast, by End-user (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.3. Market Revenue and Forecast, by End-user (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.4.3. Market Revenue and Forecast, by End-user (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.5.3. Market Revenue and Forecast, by End-user (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.6.3. Market Revenue and Forecast, by End-user (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.7.3. Market Revenue and Forecast, by End-user (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.3. Market Revenue and Forecast, by End-user (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.4.3. Market Revenue and Forecast, by End-user (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Component Type (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.5.3. Market Revenue and Forecast, by End-user (2017-2030)

Chapter 12. Company Profiles

12.1. Angio Dynamics

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Boston Scientific Corporation

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Emblation microwave

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Huber+Suhner

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Johnson & Johnson Services Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Med Waves

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Medtronic PLC

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. MedWaves Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Miramar labs

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Neu Wave Medical

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers